Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism HSP90 inhibitors(Heat shock 90kDa proteins inhibitors), ROCK2 inhibitors(Rho-associated protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H21N3O2S |
InChIKeyOIJDBECSPSHUGA-CYBMUJFWSA-N |
CAS Registry1258833-31-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Phase 2 | Japan | 01 Jul 2018 | |
Choroidal Neovascularization | Preclinical | - | 07 May 2017 | |
Choroidal Neovascularization | Preclinical | Japan | 07 May 2017 | |
Glaucoma, Open-Angle | Discovery | Japan | 06 Sep 2019 |